On Wednesday, September 18, 2019, FDA hosted a public workshop highlighting the work FDA has been doing to support and implement FDA’s Predictive Toxicology Roadmap. The recordings of that workshop are available below.  Slides are not available because they appear in the webcast. 

Location

Food and Drug Administration
White Oak Campus Bldg. 31, Great Room (Room 1503A)
10903 New Hampshire Ave.
Silver Spring, MD 20993
United States

Recordings and Agenda

Agenda

Webcast

Morning Session Recordings

  8:30 a.m. to 10:10 a.m.
10:30 a.m. to 12:00 p.m.  

Afternoon Session Recordings

1:00 p.m. to 2:20 p.m.  
2:40 p.m. to 4:00 p.m.  

For logistics questions, please contact Laurie-Anne Sayles at [email protected].

Background

In December 2017, FDA launched its Predictive Toxicology Roadmap, a six-part framework for integrating predictive toxicology methods into safety and risk assessments. Among other recommendations, the Roadmap calls for FDA research to identify data gaps and to support intramural and extramural research to ensure that the most promising technologies are developed, validated, and integrated into the product pipeline.

Past Event

FDA held its initial public hearing on the Roadmap, sponsored by FDA’s cross-agency Toxicology Working Group, on September 12, 2018.

---